Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 1993

Study Completion Date

July 31, 2004

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

aldesleukin

BIOLOGICAL

lymphokine-activated killer cells

BIOLOGICAL

therapeutic tumor infiltrating lymphocytes

DRUG

cyclophosphamide

DRUG

indomethacin

Trial Locations (1)

St. Luke's Medical Center, Milwaukee

All Listed Sponsors

lead

St. Luke's Medical Center

OTHER

NCT00002535 - Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma | Biotech Hunter | Biotech Hunter